Strategy for intention to treat analysis in randomised trials with missing outcome data
- PMID: 21300711
- PMCID: PMC3230114
- DOI: 10.1136/bmj.d40
Strategy for intention to treat analysis in randomised trials with missing outcome data
Abstract
Loss to follow-up is often hard to avoid in randomised trials. This article suggests a framework for intention to treat analysis that depends on making plausible assumptions about the missing data and including all participants in sensitivity analyses
Conflict of interest statement
Competing interests All authors have completed the unified competing interest form at
Figures
References
-
- Peduzzi P, Wittes J, Detre K. Analysis as randomised and the problem of non-adherence: an example from the Veterans Affairs randomized trial of coronary artery bypass surgery. Stat Med 1993;12:1185-95. - PubMed
-
- Committee for Proprietary Medicinal Products. Points to consider on missing data. 2001. www.emea.europa.eu/pdfs/human/ewp/177699EN.pdf.
-
- Doody R, Gavrilova S, Sano M, Thomas R, Aisen P, Bachurin S, et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study. Lancet 2008;372:207-15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical